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Interventions to strengthen the HIV prevention cascade: 
a systematic review of reviews
Shari Krishnaratne, Bernadette Hensen, Jillian Cordes, Joanne Enstone, James R Hargreaves
Summary
Background Much progress has been made in interventions to prevent HIV infection. However, development of 
evidence-informed prevention programmes that translate the eﬃ  cacy of these strategies into population eﬀ ect remain 
a challenge. In this systematic review, we map current evidence for HIV prevention against a new classiﬁ cation 
system, the HIV prevention cascade.
Methods We searched for systematic reviews on the eﬀ ectiveness of HIV prevention interventions published in 
English from Jan 1, 1995, to July, 2015. From eligible reviews, we identiﬁ ed primary studies that assessed at least one 
of: HIV incidence, HIV prevalence, condom use, and uptake of HIV testing. We categorised interventions as those 
seeking to increase demand for HIV prevention, improve supply of HIV prevention methods, support adherence to 
prevention behaviours, or directly prevent HIV. For each speciﬁ c intervention, we assigned a rating based on the 
number of randomised trials and the strength of evidence. 
Findings From 88 eligible reviews, we identiﬁ ed 1964 primary studies, of which 292 were eligible for inclusion. 
Primary studies of direct prevention mechanisms showed strong evidence for the eﬃ  cacy of pre-exposure prophylaxis 
(PrEP) and voluntary medical male circumcision. Evidence suggests that interventions to increase supply of 
prevention methods such as condoms or clean needles can be eﬀ ective. Evidence arising from demand-side 
interventions and interventions to promote use of or adherence to prevention tools was less clear, with some strategies 
likely to be eﬀ ective and others showing no eﬀ ect. The quality of the evidence varied across categories.
Interpretation There is growing evidence to support a number of eﬃ  cacious HIV prevention behaviours, products, 
and procedures. Translating this evidence into population impact will require interventions that strengthen demand 
for HIV prevention, supply of HIV prevention technologies, and use of and adherence to HIV prevention methods.
Funding Bill & Melinda Gates Foundation.
Copyright © Krishnaratne et al. Open Access article distributed under the terms of CC BY.
Introduction
Despite progress in development and delivery of 
eﬃ  cacious HIV prevention interventions, more than 
1 million people are newly infected with HIV every year.1 
UNAIDS have called for a reinvigoration of HIV 
prevention methods and suggest that 25% of global HIV 
spending should be allocated to prevention activities.2 
There is growing interest in the use of HIV prevention 
cascades to support the development and implementation 
of interventions and to facilitate resource allocation. In 
this issue, Hargreaves and colleagues3 suggest a 
reframing of HIV prevention interventions organised 
around an HIV prevention cascade that can both 
integrate evidence from diﬀ erent disciplines and be 
more helpful for programmers. Garnett and colleagues4 
use observational data from Zimbabwe to operationalise 
the idea of an HIV prevention cascade as a monitoring 
tool. In this paper, we review the available evidence for 
HIV prevention as reﬂ ected in systematic reviews of HIV 
prevention interventions published during the past 
20 years. We map the evidence base in line with the HIV 
prevention cascade, describe characteristics of inter-
ventions relevant to each area of the cascade, assess the 
type of evidence available on these interventions, and 
identify gaps and areas for future research.
Methods
Search strategy and selection of reviews
We did three independent systematic searches to identify 
systematic reviews of HIV prevention interventions 
published in English from Jan 1, 1995. Search terms 
included HIV/AIDS MeSH terms, “behav*” (behavioural 
review), “struct*” (structural review), “prevent*” and 
“intervention”, and terms speciﬁ c to each included 
biomedical intervention.
To identify systematic reviews of biomedical HIV 
prevention interventions, on Aug 15, 2014, we searched 
the Cochrane Library, MEDLINE, ISI Web of Knowledge, 
and ClinicalTrials.gov. The search ﬁ ndings were updated 
on July 20, 2015, when we extended the search to include 
Embase and no longer limited it to systematic reviews so 
that we could identify primary studies from 2012 that 
might not have been incorporated into reviews. To 
identify systematic reviews of behavioural interventions, 
on May 12–15, 2015, we searched the Cochrane Library, 
Embase, Health-Evidence.org, MEDLINE, and PsycNET 
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and for papers that described interventions implemented. 
To identify systematic reviews of structural interventions, 
we searched the Cochrane Library, MEDLINE, ISI Web of 
Knowledge, and Health-Evidence.org. We did the initial 
search for reviews about structural interventions on 
Aug 1–10, 2014, and updated the results on May 15, 2015.
Data were extracted from reviews with a data extraction 
tool (appendix 1) Reviews were eligible for inclusion if 
they systematically reviewed the evidence on the 
eﬀ ectiveness of HIV prevention interventions. Reviews 
of experimental and observational studies were included. 
There were no restrictions on populations. We excluded 
broad overviews, scoping reviews, and unsystematic 
literature reviews. 
We excluded reviews containing studies of behavioural 
interventions and structural interventions done only in 
high-income countries because we wanted to focus on 
areas in which HIV burden is highest and because the 
eﬀ ectiveness of such interventions could be context 
speciﬁ c and the heterogeneity of studies would present 
even greater challenges to data synthesis. We did not 
exclude any countries of implementation for reviews about 
the eﬃ  cacy of biomedical products, because eﬃ  cacy trials 
are not as heavily aﬀ ected by contextual factors and so we 
considered the country-focus restriction less pertinent.
Primary study identiﬁ cation and data extraction
We extracted primary studies from reviews if they 
assessed at least one of the following outcomes: HIV 
incidence, HIV prevalence, reported condom use, and 
uptake of HIV testing. For studies of direct mechanisms 
only, HIV incidence had to be a primary outcome to 
qualify for inclusion. We included condom use and 
uptake of HIV testing as proximate outcomes of 
intervention eﬀ ectiveness because these are two of the 
most commonly reported outcomes in studies that do 
not report biological HIV outcomes. Although prevention 
of mother-to-child-transmission interventions and 
outcomes were identiﬁ ed by some reviews, here we 
aimed to look speciﬁ cally at sexual transmission or 
transmission through needle sharing.
We developed an approach for minimal data extraction 
at the primary study level (appendix 2); data included the 
country of focus, target population, study design, 
reported outcomes, and overall ﬁ ndings of each study. 
We classiﬁ ed reviews and primary studies with the HIV 
prevention cascade typology described by Hargreaves 
and colleagues.3 Many primary studies ﬁ t into more than 
one category, but we allocated each study into one 
category only based on what we judged the most 
prominent component seemed to be, despite recognising 
that some interventions include components targeting 
more than one of three domains: demand-side, supply-
side, and adherence (table 1).
The demand-side domain contained studies in which 
we judged the main aim of intervention to be to inﬂ uence 
behaviour by targeting risk perception or strengthening 
awareness of, and positive attitudes towards, HIV 
prevention behaviours and technologies. These inter-
ventions include those providing information, education, 
and communication and those intended to inﬂ uence 
perceived norms through peer-based approaches. Inter-
ventions were delivered in a range of settings and to 
diﬀ erent target populations.
The supply-side domain contained studies in which we 
judged the main aim of intervention to be to inﬂ uence 
Research in context
Evidence before this study
We did a systematic review of reviews for domains across the HIV 
prevention cascade. Because we restricted our search to review 
articles, we are conﬁ dent that we would have identiﬁ ed any 
additional reviews of reviews on a similar scale to this work. Our 
search identiﬁ ed several overviews of the literature on HIV 
prevention, but few systematic reviews of reviews. One review 
published in 2013 searched for and described evidence for HIV 
prevention interventions as they pertain speciﬁ cally to young 
people and adolescents. We refer to the methods used in this 
review in our work, and we have based the appraisal and rating 
of the evidence in our review on that previous review. 
Added value of this study
To our knowledge, this is the ﬁ rst review of reviews on HIV 
prevention of this size and scope. We map the evidence across 
the HIV prevention cascade and show strong evidence for the 
eﬃ  cacy of biomedical tools such as of pre-exposure prophylaxis 
(PrEP) and voluntary medical male circumcision and for 
increasing supply of biomedical tools such as condoms or clean 
needles. By mapping the published work in this way, we present 
evidence in a format that we hope will be useful to programme 
developers and implementers and that will provide an evidence 
base to inform policy on HIV prevention.
Implications of all the available evidence
We highlight the importance of combination HIV prevention 
interventions that address structural and behavioural barriers to 
the uptake, use of, and adherence to strategies known to prevent 
HIV. Future research for biomedical tools with demonstrated 
eﬃ  cacy should focus on population-level eﬀ ectiveness. Research 
on increasing supply of these tools should use more rigorous 
study designs to measure impact in speciﬁ c populations, 
including cluster randomised trials where feasible; if not feasible, 
a range of alternative impact designs are available. Although a 
range of interventions seek to address demand for HIV 
prevention, these have rarely been studied using experimental 
trials, and, where studied, have shown heterogeneous 
eﬀ ectiveness. Similarly, studies of interventions to support use or 
adherence to HIV prevention need further adaptation and study 
aligned with the new HIV prevention cascade. 
See Online for appendix 1
See Online for appendix 2
Articles
www.thelancet.com/hiv   Vol 3   July 2016 e309
the supply of HIV prevention products and messages. 
Examples included mass condom distribution, needle 
exchange initiatives mainstreaming HIV prevention 
within other services, and treatment strategies for 
sexually transmitted infections (STIs). Some, but not all, 
of these interventions have been characterised as 
structural interventions in published work.
The adherence domain contained studies in which we 
judged the main aim of intervention to be to support 
adoption or maintenance of prevention behaviours, 
including, but not restricted to, the use of prevention 
technologies. These interventions often sought to 
inﬂ uence behavioural self-eﬃ  cacy or skills and included 
interventions such as longitudinal risk counselling. We 
also included within this group interventions that 
targeted social determinants of behaviour hypothesised 
to act as barriers to the ability of individuals to access or 
adhere to prevention, such as cash transfers or livelihood 
interventions. Again, some of these interventions have 
been identiﬁ ed as structural in the published work.
Studies in the direct mechanism domain were most 
often individually randomised trials of the eﬃ  cacy of 
biomedical products or procedures (eg, pre-exposure 
prophylaxis [PrEP] or medical male circumcision).
Within each of these domains, we identiﬁ ed speciﬁ c 
types of interventions. In describing each intervention 
type, we categorised the evidence according to the target 
population (table 1). We assessed the type and direction of 
the evidence for each of the four outcomes based on study 
design and reported ﬁ ndings (appendix 2). We used a 
framework created by Mavedzenge and colleagues5 in their 
review of the evidence for interventions for young people 
and adolescents. We ﬁ rst described the study designs in 
each category with use of the ratings A, B, or C on the basis 
of how many randomised controlled trials were published 
for a speciﬁ c outcome (table 2). We then assessed how 
many studies had ﬁ ndings that suggested intervention 
eﬀ ectiveness or not, assigning a score of 1–4 (table 2). Two 
reviewers (SK and BH) assessed the evidence for structural 
and behavioural interventions. Disagreements, although 
rare, were resolved after consultation and detailed review 
of the studies in question. One reviewer (JE) assessed the 
evidence for biomedical interventions.
Role of the funding source
The funder of the study had no role in data collection, 
data analysis, data interpretation, or writing of the report; 
however, the decision to focus only on evidence from 
low-income and middle-income countries for the 
behavioural and structural reviews was made, in part, by 
the funder. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Findings
We identiﬁ ed 88 eligible reviews (ﬁ gure 1A),6–93 from 
which we extracted 292 primary studies (ﬁ gure 1B). Of 
194 primary studies of demand-side, supply-side, or 
adherence inter ventions, 137 (71%) used observational 
study designs (ﬁ gure 2). 34 (38%) of 90 randomised 
controlled trials (RCTs) were trials of direct mechanisms 
to prevent HIV. 24 (12%) of the studies classiﬁ ed as 
demand-side, supply-side, or adherence included HIV 
incidence or prevalence or both as primary outcomes, 
whereas almost all (88%) reported condom use. 
54 primary studies from 40 reviews contributed 
evidence for information, education, and communication 
interventions (table 3). The interventions included many 
diﬀ erent approaches to inﬂ uence risk perception, 
awareness, and attitudes about preventive behaviours, 
including through multimedia, text messages, posters, 
and other forms of communication. For example, the 
Helping Each Other Act Responsibly Together (HEART) 
campaign in Zambia included a multimedia programme 
of television spots, public service announcements, radio 
advertisements, music videos, posters, and billboards to 
share messages about HIV and STI risk reduction.94 A 
secondary-school-based programme in KwaZulu-Natal 
provided sexual health and HIV prevention messages 
through either drama performances or an information 
Intervention type Subcategory (if applicable)
Demand-side 
interventions
IEC
Peer
Young people, men, women, people who use drugs, 
mass media
Young people, men who have sex with men, female sex 
workers, people who use drugs or alcohol, general
Supply-side 
interventions
Integration of HIV services
Needle or syringe programmes
Condom distribution
Community-level STI interventions
··
··
··
··
Adherence 
interventions
Counselling
Socioeconomic
Couples-based counselling, HIV testing and counselling, 
individual-level counselling, HIV-positive prevention 
Microﬁ nance interventions, cash transfer interventions
Direct 
mechanisms 
of HIV 
prevention
Voluntary medical male circumcision
Condoms
PrEP
Microbicides
STI treatment
Vaccines
Male to female transmission, female to male 
transmission, men who have sex with men
··
··
··
··
··
IEC=information, education, and communication. PrEP=pre-exposure prophylaxis. STI=sexually transmitted infections. 
 Table 1: Categorisation of evidence of HIV prevention interventions in line with the HIV prevention cascade
3 or more RCTs (might 
also include 
observational studies)
1–2 RCTs (might also 
include observational 
studies)
No RCTS; only 
observational 
studies
Consistently showed eﬀ ectiveness A1 B1 C1
Largely, but not consistently, showed 
eﬀ ectiveness
A2 B2 C2
Mixture of beneﬁ cial and ineﬀ ective or 
harmful results
A3 B3 C3
Consistent ineﬀ ective or harmful results A4 B4 C4
RCT=randomised controlled trial.
 Table 2: Assessment of strength of evidence of HIV prevention interventions across types of interventions
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booklet, both delivered in classroom settings.95 Slightly 
more than half (56%; n=30) of the information, 
education, and communication studies were of inter-
ventions focused on young people. An example is the 
MEMA Kwa Vijana cluster RCT of an intervention that 
provided primary school students with sexual health 
education through a participatory, teacher-led programme 
combined with training for health workers to provide 
sexual health services that are friendly to young people, 
as well as condom promotion and provision and 
community mobilisation.96 Almost all studies of infor-
mation, education, and communication interventions 
assessed condom use as a primary outcome (table 3).
31 reviews contributed 54 studies of peer-based inter-
ventions (table 3). Interventions in this category often 
combined peer-delivered sexual health education with 
either increased availability of direct mechanisms to 
prevent HIV, such as condoms, or community empower-
ment approaches. Studies of interventions targeted at 
female sex workers used peer-led community empower-
ment approaches to support mobilising female sex 
workers and developing a sense of community. An 
example is a peer-delivered education programme among 
establishment-based female sex workers in the 
Philippines, which combined venue-manager training 
with information on HIV and condom use.97,98 Studies 
assessing the impact of these interventions on HIV 
incidence and prevalence among female sex workers 
used experimental and observational designs, but they 
showed little evidence to support their eﬀ ectiveness on 
reducing HIV incidence or prevalence (table 3). 12 studies 
described peer-based interventions among young people. 
Examples include a project in Kenya that involved peer 
educators teaching students about HIV and life skills 
with songs, quizzes, competitions, and other methods; 
and Stepping Stones, an intensive community training 
programme designed for HIV-vulnerable communities 
in low-income countries. The participatory learning 
approach sought to empower men and women to take 
greater control over their sexual and emotional 
relationships.99,100
12 reviews contributed 35 studies on supply-side 
interventions (table 3). Approaches were often facilitated 
by policy changes, such as to increase access to free clean 
needles or subsidised condoms for populations most at 
risk (table 3). In Thailand, the 100% condom-use policy 
launched in 1989 promoted the practice of ‘‘no condom–
no sex’’ in all types of sex work through collaborations 
between local authorities, sex business owners, and sex 
workers.101 Similar approaches have been implemented 
in the Dominican Republic and Cameroon,102,103 and 
adaptations for other population groups such as young 
people have also been attempted. Among the 20 primary 
studies describing the eﬀ ectiveness of condom 
distribution interventions, three measured HIV 
prevalence, and all used observational study designs. 
Among six obser vational primary studies of exchange 
programmes for clean needles and syringes, three 
assessed HIV incidence as an outcome. Findings from 
one study supported eﬀ ectiveness, whereas two did not 
(C3; table 3). Two observational studies measured HIV 
incidence and demonstrated ﬁ ndings in support of the 
intervention (C1). Three studies (all RCTs) described 
interventions aimed at STI control. These interventions 
aimed to increase access to STI testing and treatment. 
For example, in Rakai, Uganda, an intensive STI control 
programme via home-based mass antibiotic treatment 
was rolled out and studied in a cluster RCT design.104
16 reviews provided 51 studies of interventions to 
support the adoption and maintenance of prevention 
behaviours by inﬂ uencing eﬃ  cacy and skills through 
counselling-based interventions or interventions targeting 
A
737 non-duplicate behavioural
 reviews identified
666 non-duplicate structural
 reviews identified
4798 reviews identified
3793 reviews included in
 abstract review
3395 non-duplicate biomedical
 reviews identified
1005 reviews removed (not 
 LMIC; no outcomes of
 interest; not published;
 not published in English)
257 reviews included in
 full text review
3536 reviews removed (not 
 LMIC; no outcomes of
 interest; not published;
 not published in English)
88 reviews identified
169 removed (not relevant)
1077 behavioural studies 
 identified
344 structural primary studies
 identified
1964 primary studies identified
524 primary studies included 
 in abstract review
543 biomedical primary 
 studies identified
1440 studies removed (not 
 LMIC; no outcomes of
 interest; not published;
 not published in English;
 duplicates)
292 primary studies included 
232 duplicates removed
B
Figure 1: Identiﬁ cation of systematic reviews (A) and primary studies (B) of HIV prevention interventions
LMIC=low-income or middle-income country.
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socioeconomic determinants. 26 primary studies 
described use of counselling alone or with HIV testing to 
promote HIV prevention. Seven reviews contributed 
evidence from studies describing couples-based coun-
selling inter ventions (n=10). One observational study 
assessed the eﬀ ect of couples-based counselling on HIV 
incidence with ﬁ ndings in support of the intervention (C1; 
table 3). Nine studies, including three RCTs, assessed self-
reported condom use after couples counselling and 
ﬁ ndings from these studies were in support of the 
interventions (A1; table 3). Counselling interventions were 
most often delivered via health facilities through 
interactions between providers and patients or in 
community settings by providing either individual, 
couple-based, or group-based behavioural strategies to 
reduce HIV risk behaviours. 12 studies (seven RCTs) 
assessed individual-level counselling interventions. One 
example is a programme in South Africa that focused on 
people without HIV and delivered a 60-min risk-reduction 
counselling session led by health educators and delivered 
within a health-care setting.105 Seven studies (four RCTs) 
assessed HIV-positive prevention counselling. For 
example, an RCT in South Africa studied an intervention 
that consisted of patient-centred discussions between 
counsellors and patients living with HIV during regular 
clinical visits focused on HIV risk reduction and tailored 
to speciﬁ c patient needs.106
Interventions to address socioeconomic barriers to 
adherence to HIV prevention behaviours or other direct 
prevention mechanisms were based either on incentives 
or cash payments or on strengthening livelihoods 
through microﬁ nance or related initiatives. Cash trans-
fer interventions aimed to improve school attendance 
and educational outcomes and through this mechanism 
reduce HIV infection rates among young people.107 
Other interventions used a contingency management 
model, such as that in smoking cessation programmes, 
in which regular behaviour monitoring was combined 
with ﬁ nancial incentives when the desired behaviour 
was demonstrated.108 Livelihood interventions involved 
training of participants in the development of products 
or services, access to markets, ﬁ nancial skills, and 
ﬁ nancial support or credit. The interventions sought to 
strengthen livelihoods among participants to alleviate 
poverty and increase self-eﬃ  cacy. Microﬁ nance inter-
ventions included the provision of small loans, 
assistance with the facilitation of income-generating 
activities, or provision of ﬁ nancial services.61 In some 
cases, interventions were combined with life-skills 
interventions and condom distribution including in 
studies from Kenya and Zimbabwe.109,110
29 systematic reviews (in 28 publications) in corporated 
98 primary studies of six direct mechanisms to prevent 
HIV (table 3). 38 studies, including three large RCTs, 
assessed the impact of medical male circumcision on 
HIV acquisition in heterosexual men (A1; table 3).66 
Cohort studies pre-dating the trials also indicated a 
protective eﬀ ect for heterosexual men, including those 
at high risk.67 A systematic review and meta-analysis 
covering seven primary studies, including one RCT, did 
not provide evidence of a protective eﬀ ect of male 
circumcision for women (B3).75 Four reviews provided 
19 primary studies exploring whether circumcision 
protects men who have sex with men (MSM). No RCTs 
were found, but two subanalyses of observational data by 
partner role suggest, to varying extents, that circumcision 
might give a protective eﬀ ect for MSM with a pre-
dominantly or exclusive insertive role.76,77
Two reviews describe evidence from six RCTs done 
between 2007 and 2009 to assess the eﬀ ect on HIV 
incidence of oral PrEP (of daily tenofovir disoproxil 
fumarate, with or without emtricitabine, vs placebo).82–84 
Four trials showed ﬁ ndings in support of the 
intervention, with an eﬃ  cacy of up to 75%, whereas two, 
which included women only, did not show any eﬀ ect (as 
was also the case in the more recent VOICE trial. One 
RCT assessed the eﬃ  cacy of PrEP on HIV incidence 
among people who inject drugs (B1) and one assessed 
the eﬃ  cacy of PrEP on HIV incidence among MSM 
(B1). This latter RCT, the iPrEx trial, was done in six 
countries and involved approximately 2500 men 
comparing daily tenofovir disoproxil fumarate plus 
emtricitabine versus placebo and demonstrated a 
positive eﬀ ect on incidence.111
We identiﬁ ed ﬁ ve RCTs of HIV vaccines in two reviews. 
One trial (RV144), a large trial conducted in 2009 in 
Thailand with the ALVAC-HIV vaccine and AIDSVAX 
B/E boosters, demonstrated moderate eﬃ  cacy.112 In a 
modiﬁ ed intention-to-treat analysis, vaccine eﬃ  cacy was 
31·2% (95% CI 1·1–52·1). Other vaccines trialled have 
not protected against HIV infection or reduced viral load, 
including the MRKAd5 HIV-1 gag/pol/nef subtype B 
vaccine used in the Step and Phambili studies, which 
was discontinued at interim analysis because it showed 
no protective eﬀ ect.113,114
Demand-focused interventions: 40 reviews (108 primary studies [24 RCTs])
IEC approaches  (54); peer-based approaches (54)
Use interventions: 16 reviews (51 primary studies [26 RCTs]) 
Counselling approaches (40); social determinants approaches: cash transfers (3); 
microfinance (8)
Direct mechanisms: 
29 reviews (98 primary 
studies [34 RCTs]) 
Prevention products: 
PrEP (6), condoms (4), 
VMMC (64), 
STI reduction (7), 
microbicides (12), 
vaccines (5)
 
Prevention behaviours: 
abstinence, serosorting 
(not included in this 
review)
Supply interventions: 12 reviews (35 primary studies [6 RCTs]) 
Mass condom distribution and associated policies (20); 
needle and syringe programmes and associated policies (6); 
health system policies: integration of family planning and HIV (6); STI control (3)
Figure 2: Mapping evidence for the HIV prevention cascade
RCT=randomised controlled trial. PrEP=pre-exposure prophylaxis. VMMC=voluntary medical male circumcision. 
STI=sexually transmitted infections. IEC=information, education, and communication.
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Discussion
We found evidence from several randomised trials in 
support of the eﬃ  cacy of direct mechanisms to prevent 
HIV. Evidence also suggests that supply-side inter-
ventions that increase access to these eﬃ  cacious 
technologies can be eﬀ ective, and that there is a need for 
continued research on interventions to increase demand 
for and adherence to direct mechanisms to prevent HIV. 
As the cascade highlights, demand, supply, and use of 
interventions are all crucial domains to increases in 
uptake of and adherence to direct HIV prevention 
mechanisms. The interventions and com bination of 
interventions required to translate the eﬃ  cacy of direct 
mechanisms into population-level impact will require 
monitoring for these domains to understand gaps and 
support intervention development.
Incidence Prevalence Condom use HIV testing
Number 
of 
studies
Quality 
assessment 
rating
Number 
of 
studies
Quality 
assessment 
rating
Number 
of 
studies
Quality 
assessment 
rating
Number 
of 
studies
Quality 
assessment 
rating
Demand-side interventions
Eﬀ ect of IEC interventions focused on young people6–19 3 (1) B4 1 (1) B4 28 (7) A3 ·· ··
Eﬀ ect of IEC interventions focused on men12,13,20–23 ·· ·· ·· ·· 9 (3) A2 1 (0) C1
Eﬀ ect of IEC interventions focused on women21,23 ·· ·· ·· ·· 2 (2) B3 ·· ··
Eﬀ ect of IEC interventions using mass media7,12,14 1 (1) B3 ·· ·· 9 (1) B4 ·· ··
Eﬀ ect of IEC interventions focused on people who use 
drugs16,22,24
·· ·· ·· ·· 4 (3) A1 ·· ··
Eﬀ ect of peer-based interventions focused on young 
people6,8,10,13,15,16,25–30
1 (1) B4 ·· ·· 11 (0) C2 2 (0) C1
Eﬀ ect of peer-based interventions focused on MSM30–36 ·· ·· ·· ·· 3 (1) B1 1 (0) C1
Eﬀ ect of peer-based interventions focused on female 
sex workers,9,14,18,28,30,37–44
3 (1) C4 4 (0) C4 22 (3) B2 3 (0) C1
Eﬀ ect of peer-based interventions focused on people 
who use drugs or alcohol22,28,30,32,45–47
2 (2) B4 1 (1) B4 5 (2) B3
Eﬀ ect of peer-based interventions with no population 
focus9,18,22,28,30,32,33,43
·· ·· ·· ·· 10 (2) B1 1 (0) C1
Supply-side interventions
Eﬀ ect of interventions that integrate HIV services into 
routine care41,48
·· ·· ·· ·· 1 (0) C1 5 (0) C1
Eﬀ ect of clean needle or syringe programmes49,50 2 (0) C3 6 (0) C1 ·· ·· ·· ··
Eﬀ ect of condom distribution interventions7,9,15,18,20,44,51 ·· ·· 3 (0) C1 20 (5) A1 ·· ··
Eﬀ ect of community-level STI interventions52 3 (3) A4 ·· ·· 1 (1) B4 ·· ··
Adherence interventions
Eﬀ ect of couples-based counselling45,53–57 1 (0) C1 ·· ·· 9 (3) A1 4 (3) A3
Eﬀ ect of HIV testing and counselling14,21,53,54,58 1 (1) B4 ·· ·· 8 (1) B2 3 (2) B1
Eﬀ ect of individual-level counselling14,16,22,24,37–39 1 (1) B3 ·· ·· 12 (7) A1 2 (1) B3
Eﬀ ect of HIV-positive prevention counselling22,24,53,56,59,60 ·· ·· ·· ·· 7 (4) A3 ·· ··
Eﬀ ect of microﬁ nance interventions61–64 1 (1) B4 ·· ·· 8 (4) A3 1 (1) B1
Eﬀ ect of cash transfer interventions65 2 (2) B4 2 (2) B1 1 (1) B4
Direct mechanisms
Medical male circumcision for heterosexual route risk 
(female to male)66–74
38 (3) A1 ·· ·· ·· ·· ·· ··
Medical male circumcision for heterosexual route risk 
(male to female)72,75
7 (1) B3 ·· ·· ·· ·· ·· ··
Male circumcision men who have sex with men route 
individual-level studies71,76–78
19 (0) C3 ·· ·· ·· ·· ·· ··
Condoms (heterosexual) individual-level studies79–81 4 (0) C1 ·· ·· ·· ·· ·· ··
Oral PrEP (overall) individual-level studies82–84 6 (6) A2 ·· ·· ·· ·· ·· ··
Microbicide prophylaxis individual-level studies48,71,85–90 12 (12) A3 ·· ·· ·· ·· ·· ··
STI treatment individual-level studies44,84,89,91–93 7 (7) A4 ·· ·· ·· ·· ·· ··
HIV vaccine individual-level studies71,88 5 (5) A3 ·· ·· ·· ·· ·· ··
In cells showing the number of studies, numbers in parentheses are randomised controlled trials. IEC=information, education, and communication. STI=sexually transmitted 
infections. PrEP=pre-exposure prophylaxis.  
Table 3: Number and type of studies describing HIV prevention interventions and the impact of these interventions on key outcomes
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HIV prevention technologies such as male and female 
condoms or clean injecting equipment have existed for 
several years. In recent years, evidence for the eﬃ  cacy of 
other direct mechanisms, including medical male 
circumcision and oral PrEP, has emerged. Much is left to 
learn about how these mechanisms increase coverage 
and support adherence to achieve population-level 
impacts. Our review identiﬁ ed a range of potential 
interventions addressing these elements of the cascade. 
Supply-side interventions, such as mass condom 
distribution and needle and syringe exchange initiatives, 
have shown impact on use of these methods. However, 
relatively few studies have explored the eﬀ ect of these 
interventions on HIV outcomes, and where these were 
studied, randomised trials have rarely been used.
Findings from demand-side interventions such as 
information, education, and communication and peer-
based interventions on HIV outcomes have been 
disappointing, with these interventions rarely reducing 
HIV incidence or prevalence. Few trials and studies 
identiﬁ ed in the reviews evaluated interventions to 
increase demand for medical male circumcision or 
adherence to PrEP, although evidence for this domain is 
emerging.115,116 There remains a need for additional 
research to understand why, despite supply, there is low 
uptake of these strategies and for evaluations of novel 
interventions to increase this uptake and adherence. With 
evidence arising on how to increase demand for medical 
male circumcision, systematic reviews of such strategies 
are warranted. As new direct mechanisms, including 
microbicides and vaccines, emerge, lessons learned from 
existing interventions could improve access.116
The evidence for the eﬀ ectiveness of supply-side 
interventions is a timely reminder of the gains that can be 
made in HIV prevention by making prevention products 
accessible and available to populations in need. In 
circumstances where social barriers threaten eﬀ orts to 
reduce HIV incidence, these interventions can be eﬀ ective 
at increasing access to HIV prevention methods and 
possibly reducing incidence. Policy changes are sometimes 
necessary to create the platforms to ensure biomedical and 
behavioural interventions reach and can be used by those 
who need them at scale. Overall, our review draws similar 
conclusions to Mavadzenge and colleagues:5 there is some 
evidence that in-school inter ventions can have an impact 
on some HIV outcomes, and there is proven eﬃ  cacy of 
several biomedical HIV prevention tools.
Our mapping of the literature highlights that 
distinction between the structural and the behavioural 
has not clearly distinguished interventions, and that 
classifying interventions this way might have created 
some confusion. For example, Stepping Stones was 
identiﬁ ed in reviews of interventions targeted at young 
people and women and in a review to explore the eﬀ ect of 
this intervention on individual biological outcomes 
through to structural level changes in gender norms.100 
Similarly, an intervention of social marketing to youth 
for condom use was included in reviews identiﬁ ed 
through the behavioural search and the structural 
search.103 These examples highlight that deﬁ ning the level 
at which an intervention operates might be less useful 
than would categorising it by the objective of the 
intervention (eg, to increase demand for HIV prevention 
or support adherence).
Our review also shows the many gaps that still exist in 
the literature on the eﬀ ectiveness of interventions for 
HIV prevention, particularly when it comes to demand-
side, supply-side, and adherence interventions. Although 
we identiﬁ ed a large number of studies across these 
typologies, most were observational in design and often 
relied on self-reported behavioural outcomes. This might 
be interpreted as meaning that these studies contribute 
less to the evidence base for eﬀ ectiveness than do those 
using randomised trial designs. However, observational 
studies are necessary and important when randomisation 
is either not feasible or even unethical, providing strong 
evidence that an intervention likely had an eﬀ ect if the 
design is robust. As stated, our goal here is to describe 
the current state of HIV prevention research and to 
highlight key research gaps. As such, it is necessary to 
describe the evidence from these studies, alongside that 
from studies with more robust study designs to accurately 
map the state of the evidence.
Our mapping method has several limitations. First, our 
search strategy might have missed reviews of prevention 
technologies. However, in light of the large overlap found 
between the primary studies included in the reviews, we 
consider it unlikely that this would have led to us 
excluding a large number of relevant primary studies or 
have aﬀ ected our overall conclusions. Second, because 
we carried out a review of reviews, we only assessed 
studies that were themselves included in a systematic 
review (no extra studies of biomedical HIV prevention 
interventions were included when we opened the search 
to primary papers). Such an approach will inevitably 
miss recently published studies. For example, the FACTS 
001 trial, a phase 3, multicentre RCT in South Africa that 
evaluated the safety and eﬀ ectiveness of pericoital 
tenofovir 1% gel, announced trial results in early 2015 
and was therefore not included in any systematic reviews 
we identiﬁ ed. The study found no evidence of an eﬀ ect 
on HIV incidence.117 Results of two trials showing eﬃ  cacy 
of oral PrEP in MSM were also published after our 
search.118,119 The one review we identiﬁ ed that described 
cash transfer interventions included 16 studies, but at the 
time of publication, only three studies had reported 
relevant data on HIV-related outcomes. Subsequently, 
ﬁ ndings from at least one study, the HPTN 068 trial, 
have been released.120
Third, we identiﬁ ed a large number of primary studies 
of complex interventions that had components aimed at 
increasing demand through information, education, and 
communication and peer interventions. We aimed to 
map interventions to the HIV prevention framework by 
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the main intervention component. However, classi-
ﬁ cation was subjective and reviewers might classify 
inter ventions diﬀ erently or might have opted to 
categorise interventions into multiple categories. The 
implications of this are that we might under-report 
available evidence in a certain category. We opted to 
classify studies into only one category to avoid overstating 
the evidence available on HIV prevention interventions. 
Additionally, two reviewers discussed classiﬁ cation in 
detail and consulted a third if there was strong disagree-
ment and so it is unlikely that any mis classiﬁ cation 
would change our ﬁ ndings substantially.
Fourth, where possible, we discussed the available 
evidence for biological HIV outcomes. However, self-
reported behavioural outcomes were often the only 
measure of intervention eﬀ ect presented in studies, 
particularly those describing demand-side, adherence, and 
supply-side interventions. Such outcomes have insuﬃ  cient 
ability to show actual changes in behaviour; however, only 
including studies that reported biological HIV outcomes 
would have vastly reduced the number of primary studies 
assessed. The inclusion of studies assessing condom use 
as an outcome allows us to describe evidence from key 
interventions that align with the prevention cascade. By 
including these studies, we highlight evidence showing 
that interventions do inﬂ uence proximate measures of 
demand, supply, and adherence.
Finally, our objective was to do a systematic review of 
systematic reviews. Our objective was not to assess the 
methodological rigour of the primary studies identiﬁ ed by 
these reviews. Our decision to categorise primary studies, 
rather than the reviews themselves, into the speciﬁ c 
cascade domains was led by the large overlap across 
primary studies included in the reviews. As such, our 
review provides an overview of the rigour and strength of 
the evidence; however, it does not provide nuanced detail of 
the quality of the primary studies.5 Given the minimal data 
extraction that we did at the level of the primary study, we 
cannot comment on hetero geneity across populations 
included in the studies. We appreciate that it is important 
to understand whether populations in studies with robust 
study designs and showing consistent eﬀ ectiveness are 
similar or diﬀ erent to those in studies using mostly 
observational study designs, and demonstrating 
inconsistent or no eﬀ ective ness. Understanding the 
potential relationship between evidence quality and the 
populations studied is an important next step. Again, our 
objective was not to critically appraise primary studies or 
speciﬁ c interventions but to map where along the 
prevention cascade evidence of interventions is available, 
the number and type of studies, and whether these studies 
generally supported the intervention or not. A primary goal 
was to highlight areas in which more research is needed.
The current evidence base on HIV prevention shows 
that we have methods that work at the individual level, 
and that the goal of ensuring population-level eﬀ ect is 
achievable through the use of interventions that support 
demand for HIV prevention, supply of HIV prevention 
technologies, and adherence to the direct mechanisms 
that prevent HIV. The use of an HIV prevention cascade 
that includes these domains provides a framework to 
understand why a proven direct mechanism is failing to 
have a population-level impact and support the develop-
ment and implementation of interventions to target these 
domains. Systematic reviews that explore the current 
evidence in the four categories identiﬁ ed in this paper 
should be done to understand fully what works, for 
whom, and under which circumstances. This is an 
essential next step for the evidence mapping we have 
initiated here. Future research that builds on the current 
evidence base and shows approaches to gaining impact 
for HIV prevention methods is necessary to ensure 
intervention eﬀ ectiveness.
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